Psoriatic Arthritis Clinical Trials

Is Joint Pain Holding You Back Every Day?

Explore New Possibilities with Psoriatic Arthritis Clinical Trials

Psoriatic arthritis is a chronic inflammatory condition that can cause joint pain, stiffness, swelling, and tenderness. It can affect different parts of the body and may make everyday activities, work, exercise, and other routines more difficult.

For people living with active psoriatic arthritis despite previous treatment, finding an approach that helps manage symptoms can be an ongoing challenge.

Revive Research Institute is conducting psoriatic arthritis clinical trials to evaluate investigational treatment options for people with active psoriatic arthritis. These studies aim to evaluate potential new treatments and contribute to a better understanding of how psoriatic arthritis can be managed.

By participating in psoriatic arthritis research studies, eligible participants can contribute to research that may help advance future treatment options for people living with psoriatic arthritis.

Participation Criteria

To be eligible for clinical trials for psoriatic arthritis, participants must:

  • Be 18 years of age or older
  • Have a diagnosis of active psoriatic arthritis despite previous treatment

*Additional eligibility criteria may apply.

*Participation in a psoriatic arthritis clinical trial may provide access to expert medical care, regular health monitoring, and investigational therapies at no cost. Health insurance is not required to take part in these studies, and joining a psoriatic arthritis research study may help advance future therapies.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.
SLE & Lupus Nephritis Flyer

About the Psoriatic Arthritis Clinical Trial

Psoriatic arthritis can cause persistent inflammation that affects the joints and may lead to pain, stiffness, and difficulty with movement. For some individuals, symptoms may continue despite previous treatment, creating a need for additional treatment options. Psoriatic arthritis clinical trials in Michigan are designed to evaluate investigational treatments and help researchers better understand potential approaches to managing active psoriatic arthritis.

Revive Research Institute is conducting research to evaluate investigational treatment options for eligible participants. The study will assess the treatment according to the specific research protocol and may help contribute to the development of future options for people living with psoriatic arthritis.

Participants who meet the eligibility requirements and qualify for enrollment may receive study-related care, assessments, and investigational treatment as outlined by the study protocol.

*All study procedures, doctor visits, and study-related medications are provided free of charge. Insurance is not required, and participants may be compensated for time and travel.

*To take the next step, complete the form above, and a member of our clinical research team will contact you for a brief pre-screening. You’ll discuss your health history and learn if you qualify for the study.

Get Started: What to Expect?

If you qualify for a psoriatic arthritis clinical trial in Michigan, you may have the opportunity to participate in research evaluating an investigational treatment for active psoriatic arthritis.

After submitting your information, our research team will contact you for a short pre-screening call. If you meet the initial requirements, you may be invited to our research site for a screening visit, where the research team will review your medical history and perform study-related assessments.

Those who qualify will review and sign an informed consent form (ICF), which explains the study procedures, potential risks, and potential benefits. Once enrolled, participants will receive the study treatment and ongoing care according to the research protocol.

Our research team will help participants understand what to expect throughout the study and provide support during their participation.

By taking part in psoriatic arthritis research studies, you can contribute to research that may help advance future treatment options for people living with active psoriatic arthritis.

Age

18 years or older

Condition

Active Psoriatic Arthritis

Location

Michigan

Understanding Psoriatic Arthritis

Psoriatic Arthritis Clinical Trials

Psoriatic arthritis is a type of inflammatory arthritis associated with psoriasis. It can affect the joints as well as other areas of the body, and symptoms can vary from person to person.

Common Symptoms:

  • Joint pain
  • Joint stiffness
  • Joint swelling and tenderness
  • Stiffness that may be worse in the morning
  • Swelling of fingers or toes
  • Pain or stiffness in the lower back
  • Nail changes
  • Fatigue
  • Areas of psoriasis on the skin

Common Risk Factors:

  • Having psoriasis
  • Family history of psoriasis or psoriatic arthritis
  • Immune system factors
  • Age
  • Other individual risk factors

Active psoriatic arthritis can continue to affect daily life even after previous treatment. Ongoing clinical trials for psoriatic arthritis are important for evaluating new investigational treatment approaches and expanding our understanding of this condition.

Frequently Asked Questions (FAQs)

Psoriatic arthritis is a chronic inflammatory form of arthritis associated with psoriasis. It can cause joint pain, stiffness, swelling, and inflammation and may affect different joints and areas of the body.

Active psoriatic arthritis means that the condition is currently causing signs or symptoms of inflammation. The specific definition of active disease and eligibility requirements can vary depending on the clinical trial protocol.

Participating in psoriatic arthritis research studies in Michigan may give eligible participants an opportunity to contribute to research evaluating investigational treatments for active psoriatic arthritis. Participants may also receive study-related medical care and monitoring according to the study protocol.

The current study is looking for adults aged 18 years or older who have active psoriatic arthritis despite previous treatment. Additional eligibility criteria may apply, and participation is determined after the required screening process.

Study-related visits, assessments, and investigational medications may be provided at no cost to eligible participants, depending on the study protocol. Insurance requirements and compensation for time and travel may vary.